Extension of Separation and Consulting Agreement between Adamas Pharmaceuticals, Inc. and Rajiv Patni
Contract Categories:
Human Resources
›
Separation Agreements
Summary
Adamas Pharmaceuticals, Inc. and Rajiv Patni have agreed to extend the consulting period under their existing Separation and Consulting Agreement from July 15, 2020 to October 15, 2020. All other terms of the original agreement remain unchanged. This extension is confirmed by both parties' signatures. The agreement also references a Confidential Information and Inventions Assignment Agreement as an exhibit.
EX-10.1 2 adms10qq32020ex101.htm EX-10.1 Document
Exhibit 10.1
July 15, 2020
Via Hand Delivery
Rajiv Patni
c/o Adamas Pharmaceuticals, Inc.
Re: Separation and Consulting Agreement Extension
Dear Rajiv:
Thank you so much for agreeing to extend the term of the Consulting Period under your Separation and Consulting Agreement dated as of February 20, 2020 (the “Agreement”). The provisions of each of the first paragraph of Section 2 and of Section 2(j)(i) of the Agreement are amended to replace July 15, 2020 with October 15, 2020. Except as set forth herein, the terms and conditions of the Agreement remain unchanged.
If you are in agreement with the foregoing, please execute the enclosed copy of this letter and return it to me at your earliest convenience.
Sincerely,
Adamas Pharmaceuticals, Inc.
| By: | /s/ Eric Schlezinger | ||||||||||
| Eric Schlezinger | |||||||||||
| Head of HR | |||||||||||
Exhibit A – Confidential Information and Inventions Assignment Agreement
Accepted and Agreed:
| /s/ Rajiv Patni | |||||||||||
| Rajiv Patni | |||||||||||
| July 18, 2020 | |||||||||||
| Date | |||||||||||
218089366 v4
